{"id":"https://genegraph.clinicalgenome.org/r/9d89770a-ccf7-43cd-8c0c-0d5fc603829fv1.1","type":"EvidenceStrengthAssertion","dc:description":"KCNE2 encodes the beta-subunit of voltage-gated potassium channels and is thought to assemble with KCNH2 to form Ikr (the rapidly activating delayed rectifier cardiac potassium channel). There is strong evidence associating KCNE2 with acquired LQTS, however, KCNE2 variants reported for LQTS routinely require secondary provocation to induce phenotype, persuading the Expert Panel to conclude that KCNE2 has no supportive evidence as a cause of LQTS in the absence of provoking factors (PMID 28794082). \nNote: All LQTS genes were curated by 3 separate blinded teams. The evidence and scores reached by these 3 teams were reviewed by the LQTS Clinical Domain Expert Panel. For a detailed discussion of this group's work and the separate scores of the 3 teams please see \"Adler et al. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation 2020;141(6):418-428. doi: 10.1161/CIRCULATIONAHA.119.043132â€","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/9d89770a-ccf7-43cd-8c0c-0d5fc603829f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9912be79-b172-46ca-a67c-99698de5590b","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9912be79-b172-46ca-a67c-99698de5590b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10025","date":"2020-12-15T00:23:41.412Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/9912be79-b172-46ca-a67c-99698de5590b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10025","date":"2021-01-08T19:16:10.842Z","role":"Publisher"}],"curationReasonDescription":"No supportive evidence as a cause of LQTS in the absence of provoking factor","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9912be79-b172-46ca-a67c-99698de5590b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9912be79-b172-46ca-a67c-99698de5590b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/484fd304-071c-461a-875b-b0b6029ee415","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74058606-7e01-4e3b-9b7d-5140bb610a54","type":"Finding","dc:description":"KCNQ1 has been associated with LQT syndrome.  KCNE2 had been previously shown to interact with HERG (KCNH2), but not with KCNQ1 in the construct of potassium channels.  However, the previous work was done in Xenopus oocytes.  This work was done in human COS cells, and the interaction was demonstrated.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11101505","rdfs:label":"Interaction with KCNQ1","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/130b6cc2-9aea-4fcd-8fd4-55714138d87e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d26886b9-aad1-43be-bc61-2dfedc35f0d3","type":"Finding","dc:description":"Mutations in the KCNE2 gene result in prolongation of the QT interval, disrupting the rhythm of the cardiac cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15292247","rdfs:label":"Co-expression in neonatal rat ventrcular myocytes","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0684481c-35ab-487f-a9d9-58fef6272329","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e086ff9-fa4f-4149-877f-61659286a41b","type":"Finding","dc:description":"The variants identified in this paper, which were tested in vitro, all caused increased voltage dependence of channel activation, which translates into a decreased potassium flow, and increased QT interval during repolarization.  This is consistent with the phenotype of LQT syndrome.  Of relevance is the statement that the variants are likely to be well tolerated in the absence of additional factors (drugs, gender), and therefore, these appear to be risk alleles, rather than pathogenic alleles.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10219239","rdfs:label":"Whole cell current measurements using Xenopus system","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/90dc3529-425b-4ce6-9431-5d61c1f49f89","type":"EvidenceLine","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70fb1b4b-c3ae-45c5-9d2c-8593625aa2cc","type":"Finding","dc:description":"Impact of variants on K+ channels would cause prolonger QT interval.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11927665","rdfs:label":"Electrophysiology","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9912be79-b172-46ca-a67c-99698de5590b_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb02cb3b-c486-492d-91ab-494bede2936a","type":"EvidenceLine","dc:description":"significant larger current spikes of HERG-MiRP1 channels; these changements in currents may result in an increased risk of arrhythmia","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8090c3cd-75b9-402b-ac3b-0247ed4c6dae","type":"FunctionalAlteration","dc:description":"significant larger  current spikes of HERG-MiRP1 channels; these changements in currents may result in an increased risk of arrhythmia","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12923204","rdfs:label":"Electrophysiology using CHO cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5af565e2-2d5b-4013-8767-ebfab4bec52c","type":"EvidenceLine","dc:description":"In MiRP1-hERG channels there is a reduction of Ikr currents density, the inactivation in mutant channels is more comprehensive and the recovery from the inactivation is slower","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be071470-0723-476e-af65-89e47cc0f3d0","type":"FunctionalAlteration","dc:description":"In MiRP1-hERG channels there is a reduction of Ikr currents density, the inactivation in mutant channels is more comprehensive and the recovery from the inactivation is slower","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18006462","rdfs:label":"CHO cells electrophysiology"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/938fdd9e-9d37-4a03-87fb-0232274ab62a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1043548a-442d-43d6-bf83-d45be14ab064","type":"FunctionalAlteration","dc:description":"The voltage dependence of channel activation was increased, which caused a decrease in K+ flow, and longer time to repolarization for 3 variants that were identified in a patient cohort (and not in 1010 controls).  Another variant that was also identified in controls did not show the same physiological impact on function.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10219239","rdfs:label":"Identification of variants in patient population"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/9912be79-b172-46ca-a67c-99698de5590b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9912be79-b172-46ca-a67c-99698de5590b_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b2c0e30-a1a4-44fc-87e8-82af12f2d11d","type":"EvidenceLine","dc:description":"This was a study to identify variants in the KCNE2 gene in individuals with ether drug induced or inherited or sporadic LQT phenotype, who did not already have variants in other known disease genes.   Although there was no case control matching, and no stats were provided, the variants were evaluated by biochemical methods and it was shown that they did impact the performance of the K+ channel in a model system. However, important to note that the variants were considered as \"likely to be tolerated\" normally, only causing predisposition to disease in the context of additional negative stimuli.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b2c0e30-a1a4-44fc-87e8-82af12f2d11d_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10219239","rdfs:label":"Abbott et al study","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/05a6cfe3-8b6a-418a-94c7-3319089c7131","type":"Cohort","allGenotypedSequenced":259,"alleleFrequency":0.01158301158301158,"detectionMethod":"3 sets of primers were used to amplify the KCNE2 gene coding region.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b2c0e30-a1a4-44fc-87e8-82af12f2d11d_cc_evidence_item"}],"numWithVariant":3},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/79bce430-de87-4bf0-b389-4771b30f7c19","type":"Cohort","allGenotypedSequenced":1010,"alleleFrequency":0,"detectionMethod":"3 sets of primers were used to amplify the KCNE2 gene coding region.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b2c0e30-a1a4-44fc-87e8-82af12f2d11d_cc_evidence_item"}],"numWithVariant":0},"method":{"id":"cg:AggregateVariantAnalysis"},"statisticalSignificanceType":"","statisticalSignificanceValueType":""}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/91855a1d-4c5d-4281-9172-fb35b3156660","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91855a1d-4c5d-4281-9172-fb35b3156660_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23714088","rdfs:label":"pediatric patients with LQTS","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/ccd58902-d67a-4bcb-a75d-da3452c8ae1b","type":"Cohort","allGenotypedSequenced":43,"alleleFrequency":0.02325581395348837,"detectionMethod":"Comprehensive genetic mutational analysis of 5 LQTS susceptibility genes was performed on all patients through a commercial laboratory\"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91855a1d-4c5d-4281-9172-fb35b3156660_cc_evidence_item"}],"numWithVariant":1,"relatedCondition":{"id":"obo:MONDO_0002442"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/b1afb792-93d7-4389-9a3e-d13fa09d574e","type":"Cohort","allGenotypedSequenced":105,"alleleFrequency":0,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91855a1d-4c5d-4281-9172-fb35b3156660_cc_evidence_item"}],"numWithVariant":0},"method":{"id":"cg:AggregateVariantAnalysis"},"statisticalSignificanceType":"","statisticalSignificanceValueType":""}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0e4dc2de-47ac-4af2-80a1-e16870a364c9","type":"EvidenceLine","dc:description":"Weak case control study, but the functional analysis of the sole variant identified in KCNE2.  However, mutant form of KCNE2 appeared to form normal channels, localize appropriately and have some function, although the inactivation kinetics were somewhat altered.  Therefore, the clinical impact of this variant is unclear- may be a risk allele but not likely pathogenic on its own. Also the variant in this family was inherited from the asymptomatic father, while the mother, who had a borderline QT interval, did not have the variant.  Strongly suspect another variant might have been present in the family?","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e4dc2de-47ac-4af2-80a1-e16870a364c9_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12185453","rdfs:label":"Isbrandt et al","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/f49fe69c-6077-402c-8655-68be0c20b98e","type":"Cohort","allGenotypedSequenced":150,"alleleFrequency":0.006666666666666667,"detectionMethod":"SSCP analysis followed by Sanger for any variants identified in KCNE1, KCNE2, SCN5A, KCNQ1 and KCNH2","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e4dc2de-47ac-4af2-80a1-e16870a364c9_cc_evidence_item"}],"numWithVariant":1,"relatedCondition":{"id":"obo:MONDO_0002442"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/5624736f-723f-4fe5-90e1-44771cec0e02","type":"Cohort","allGenotypedSequenced":100,"alleleFrequency":0,"detectionMethod":"SSCP analysis followed by Sanger for any variants identified in KCNE1, KCNE2, SCN5A, KCNQ1 and KCNH2","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e4dc2de-47ac-4af2-80a1-e16870a364c9_cc_evidence_item"}],"numWithVariant":0},"method":{"id":"cg:AggregateVariantAnalysis"},"statisticalSignificanceType":"","statisticalSignificanceValueType":""}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e0929ed6-0cba-47c4-af97-ede82ff21050","type":"EvidenceLine","dc:description":"The frequency of KCNE2 variants in controls is 2800x the prevalence of LQT6","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0929ed6-0cba-47c4-af97-ede82ff21050_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28794082","rdfs:label":"40 LQT6 cases + 17 from literature","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/aefabfa5-436d-496c-b979-959910daee28","type":"Cohort","allGenotypedSequenced":40,"alleleFrequency":1,"detectionMethod":"sanger sequencing of LQT genes: KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2 and others","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0929ed6-0cba-47c4-af97-ede82ff21050_cc_evidence_item"}],"numWithVariant":40,"relatedCondition":{"id":"obo:MONDO_0002442"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/69dd19a8-2a8d-4dec-a858-8c833b61c362","type":"Cohort","allGenotypedSequenced":60706,"alleleFrequency":0.01415016637564656,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0929ed6-0cba-47c4-af97-ede82ff21050_cc_evidence_item"}],"numWithVariant":859},"method":{"id":"cg:AggregateVariantAnalysis"},"statisticalSignificanceType":"","statisticalSignificanceValueType":""}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9912be79-b172-46ca-a67c-99698de5590b_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e60a4a6-34c0-49f2-a210-b103a3c24aa4_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18006462","rdfs:label":"proband","family":{"id":"https://genegraph.clinicalgenome.org/r/2e60a4a6-34c0-49f2-a210-b103a3c24aa4","type":"Family","rdfs:label":"proband","ethnicity":{"id":"cg:NotHispanicOrLatino"}},"phenotype":[{"id":"obo:HP_0001279"},{"id":"obo:HP_0001695"},{"id":"obo:HP_0001663"}],"phenotypePositiveAllelePositive":1}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9912be79-b172-46ca-a67c-99698de5590b_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cbbb39fb-7e84-463a-b9db-c82b0426d25e_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc284671-0ff9-4de2-a183-eca3ef726c03","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23631727","rdfs:label":"55 yo caucasian male","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":55,"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cbbb39fb-7e84-463a-b9db-c82b0426d25e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23631727","allele":{"id":"https://genegraph.clinicalgenome.org/r/bebb8562-e319-4e69-82ef-249b52794f30","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_172201.2(KCNE2):c.161T>C (p.Met54Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA253741"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Disputed","sequence":1767,"specifiedBy":"GeneValidityCriteria8","strengthScore":4.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ar_CgM2U-Jo","type":"GeneValidityProposition","disease":"obo:MONDO_0002442","gene":"hgnc:6242","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9912be79-b172-46ca-a67c-99698de5590b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}